Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). [electronic resource]
Producer: 20041026Description: 397-414 p. digitalISSN:- 0169-409X
- Biological Availability
- Carbamazepine -- chemistry
- Cefuroxime -- analogs & derivatives
- Chemistry Techniques, Analytical
- Crystallography
- Decision Trees
- Drug Approval -- methods
- Drug Stability
- Drugs, Generic -- chemistry
- Enalapril -- chemistry
- Humans
- Molecular Conformation
- Phase Transition
- Prazosin -- analogs & derivatives
- Quality Control
- Ranitidine -- chemistry
- Solubility
- Sulfonamides -- chemistry
- Technology, Pharmaceutical
- Therapeutic Equivalency
- Torsemide
- United States
- United States Food and Drug Administration
- Warfarin -- chemistry
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.